{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-013626","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.894934+00:00","generated_at":"2026-06-12T04:02:01.062109+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ReShape Lifesciences Q2 revenue down $0.6M YoY to $2.3M; operating expenses cut 53%","bullets":["Revenue $2.3M (-$0.6M vs Q2 2022); gross margin 53.0% vs 65.1%.","Non-GAAP adjusted EBITDA loss improved to $3.7M from $7.8M a year ago.","Cash $4.7M, debt-free; completed $2.5M registered direct offering in April.","Filed PMA supplement for Lap-Band 2.0; expects FDA feedback by year-end or early 2024.","Signed Hive preferred partner AI SMS platform; consultations up 107% at select accounts."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-013626","json":"https://secwatch.observer/filing/0001558370-23-013626.json","markdown":"https://secwatch.observer/filing/0001558370-23-013626.md","text":"https://secwatch.observer/filing/0001558370-23-013626.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000155837023013626/0001558370-23-013626-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000155837023013626/rsls-20230807x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T04:02:01.062109+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b1e6274b1853f3cc6ea8432a1fbc23fcb3fd018a","claim":"Vyome Holdings, Inc reported financial results for the three and six months ended June 30, 2023.","evidence_excerpt":"On August 7, 2023, ReShape Lifesciences Inc. (the “Company”) issued a press release announcing its financial results for the three and six months ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427570/000155837023013626/0001558370-23-013626-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and six months ended June 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}